|
Volumn 359, Issue 5, 2008, Pages 529-533
|
Simvastatin with or without ezetimibe in familial hypercholesterolemia [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COLESTYRAMINE;
EZETIMIBE PLUS SIMVASTATIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NICOTINIC ACID;
SIMVASTATIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
C REACTIVE PROTEIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
AZETIDINE DERIVATIVE;
EZETIMIBE;
HYPOCHOLESTEROLEMIC AGENT;
ATHEROGENESIS;
ATHEROSCLEROSIS;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
CORONARY RISK;
DIET;
DISEASE COURSE;
FAMILIAL HYPERCHOLESTEROLEMIA;
HUMAN;
LETTER;
PRIORITY JOURNAL;
PROPHYLAXIS;
TREATMENT OUTCOME;
ARTERY INTIMA PROLIFERATION;
DISEASE SEVERITY;
HEART EJECTION FRACTION;
HEART FAILURE;
HYPERLIPIDEMIA;
INFLAMMATION;
UNSPECIFIED SIDE EFFECT;
BLOOD;
DRUG COMBINATION;
HYPERLIPOPROTEINEMIA TYPE 2;
INTIMA;
NOTE;
PATHOLOGY;
TUNICA MEDIA;
ANTICHOLESTEREMIC AGENTS;
AZETIDINES;
CHOLESTEROL, LDL;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPERLIPOPROTEINEMIA TYPE II;
SIMVASTATIN;
TUNICA INTIMA;
TUNICA MEDIA;
|
EID: 48249089651
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc080981 Document Type: Letter |
Times cited : (4)
|
References (5)
|